Business Council
The New York Stem Cell Foundation's Business Council is comprised of leaders from biotechnology, pharmaceutical and venture capital companies who share the Foundation's vision and mission to advance stem cell research.
NYSCF understands the critical importance of creating partnerships with industry to further this innovative research. The Business Council assists the Foundation in developing strategies for working with the private sector to advance stem cell research, establishing collaborations with industry partners to maximize the possibilities of developing therapeutics derived from research supported by NYSCF.
Scott Bruder, MD, PhD
Senior Vice President & Chief Technology Officer - Becton Dickinson
Eli Casdin
Casdin Capital
Ashley Dombkowski, PhD
Chief Business Officer and VP of Operations - 23andMe
Geoff Duyk, MD, PhD
Partner - TPG Biotech LLC
Corey Goodman, PhD
President, Biotherapeutics and Bioinnovation Center - Pfizer
Daniel Marshak, PhD
Senior Vice President & Chief Scientific Officer - PerkinElmer
Mahendra Rao, PhD
Vice President of Stem Cell Research - Life Technologies
Lee Rubin, PhD
NYSCF Scientific Advisor
Director of Translational Research - The Harvard Stem Cell Institute
Director of Translational Research - The Harvard Stem Cell Institute
George Scangos, PhD
President & Chief Executive Officer - Exelixis
Richard Scheller, PhD
Executive Vice President, Research and Chief Scientific Officer - Genentech
Joop Sistermans
Former Executive Vice President - Akzo Nobel
Patrick Vallance, MD, PhD
Senior Vice President of Drug Discovery - GlaxoSmithKline
